MedTrace Logo

Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section

NCT02937792 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-10-19

No results posted yet for this study

Summary

To test the safety of high dose spinal in elective CS after prolonged sitting position.

Conditions

  • Spinal Anesthesia

Interventions

DRUG

intrathecal 15 mg bupivacaine

spinal anesthesia with a large dose of bupivacaine 0.5% in elective caesarean section

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02937792 on ClinicalTrials.gov